{
    "nctId": "NCT02290834",
    "briefTitle": "Chemotherapy-induced Cognitive and Brain Changes in Older Adults With Breast Cancer",
    "officialTitle": "Chemotherapy-induced Cognitive and Brain Changes in Older Adults With Breast Cancer",
    "overallStatus": "RECRUITING",
    "conditions": "Impaired Cognition, Chemo-brain, Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NON_RANDOMIZED",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 200,
    "primaryOutcomeMeasure": "Change in cognitive performance scores",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Breast cancer patients treated with chemotherapy- Group 1 (experimental group)\n\n  * Participants must meet the following criteria on screening examination to be eligible to participate in the behavioral +/- imaging components of study\n  * New diagnosis histologically confirmed invasive breast cancer\n  * Treatment plan to include chemotherapy\n  * Female subjects age \u2265 60 years.\n  * Life expectancy \u2265 1 year\n  * Karnofsky Performance Score (KPS) \u2265 80\n  * Ability to understand and the willingness to sign a written informed consent document.\n* Non-treated breast cancer patient controls- Group 2 (control group)\n\n  * Participants must meet the following criteria on screening examination to be eligible to participate in the behavioral +/- imaging components of study:\n  * New diagnosis histologically confirmed invasive breast cancer\n  * Treatment plan does not include chemotherapy\n  * Age \u2265 60 years.\n  * Life expectancy \u2265 1 year\n  * Karnofsky Performance Score (KPS) \u2265 80\n  * Ability to understand and the willingness to sign a written informed consent document.\n* Healthy control subjects- Group 3 (control group)\n\n  * Participants must meet the following criteria on screening examination to be eligible to participate in the behavioral +/- imaging components of study:\n  * Age \u2265 60 years.\n  * Life expectancy \u2265 1 year\n  * Karnofsky Performance Score (KPS) \u2265 80\n  * Ability to understand and the willingness to sign a written informed consent document.\n  * Participants with well-controlled vascular risk factors, such as treated hypertension, treated hyperlipidemia or well-controlled Type II diabetes (glucose levels \\<250) may be included.\n  * Serum Pregnancy Testing: STAT quantitative serum hCG pregnancy testing for all women of childbearing potential. Imaging will not start until and unless the test result returns negative.\n\nExclusion Criteria:\n\n* Participants who exhibit any of the following conditions at screening will not be eligible for admission into the study:\n\n  * Participants with clinical or radiographic evidence of metastatic CNS disease\n  * Subjects with MMSE scores below 24\n  * Active or history of major psychiatric disorders such as schizophrenia, schizoaffective disorder, major affective disorder in mid-life, or treatment with ECT (Mild depression that is well treated with stable dose of SSRI antidepressants may be allowed).\n  * Substance abuse within the past 2 years\n  * Huntington's disease, hydrocephalus or seizure disorder\n* In addition to exclusion criteria above, participants who exhibit any of the following conditions at screening will not be eligible for admission into imaging portion of the study:\n\n  * Participants with contraindications to MRI (i.e., implanted metal including pacemakers, cerebral spinal fluid shunts, aneurysm clips, artificial heart valves, ear implants or metal/foreign objects in the eyes and those with a history of claustrophobia), injuries to the eyes with metal without X-ray documentation that metal was removed",
    "sex": "FEMALE",
    "minimumAge": "60 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}